PharmiWeb.com - Global Pharma News & Resources
09-Apr-2020

M1 Kliniken AG: Corona pandemic: M1 Group extends clinic and practice closures until 24 April 2020

DGAP-News: M1 Kliniken AG / Key word(s): Forecast/Sustainability
09.04.2020 / 09:00
The issuer is solely responsible for the content of this announcement.

Corona pandemic: M1 Group extends clinic and practice closures until 24 April 2020

Berlin, 09.04.2020 - Following the federal and state governments announcement to continue the ban on contact to at least 19/20 April 2020, M1 Kliniken AG has decided to keep its own clinics and practices closed until 24 April 2020. Internally, however, plans for the reopening have already begun. M1 expects a road map from the German government shortly on how public life can be gradually resumed and thus make beauty treatments feasible again.

Due the very robust structure of M1's business model, important cost items are being reduced in correlation with the closures. In addition, M1 is taking advantage of government programs of short-time work and is negotiating with suppliers to reduce costs. Based on its strong cash position, M1 is thus well equipped to overcome the closure period without long-term adverse effects. The management assumes that following the reopening of the clinic and practice operations, the pre-existing capacity levels can be achieved in the foreseeable future.

Concurrently, cooperations with local health authorities and other bodies are taking shape. For example, M1 is providing a support team for the Treptow-Köpenick health authority, which is being deployed for mass testing of potentially affected persons, e.g. in nursing and old people's homes. There has been a high level of interest among the M1 workforce to participate in this initiative to support public efforts to cope with the pandemic. Other extensive forms of such cooperation are currently in a planning phase or final coordination.

About M1 Kliniken AG
M1 Kliniken AG is the leading provider of beauty medicine health services in Germany. In the aesthetic and surgical field, the group offers products and services of the highest quality. Under the brands M1 Med Beauty, M1 Laser and M1 Dental, beauty medical treatments are currently offered at more than 35 locations. The M1 Schlossklinik for plastic and aesthetic surgery in Berlin, with six operating theatres and 35 beds, is one of the largest and most modern facilities of its kind in Europe. Since the end of 2018, M1 has been pushing ahead with its international expansion and is currently active in Austria, Switzerland, the Netherlands, UK and Australia. The Group is now also growing in other European countries. It markets high-quality products to private customers, doctors, pharmacies and wholesalers under the M1 Select and M1 Aesthetics brands. www.m1-kliniken.de

Contact:
M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Phone: +49 (0)30 347 47 44 14
E-mail: ir@m1-kliniken.de
 



09.04.2020 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: M1 Kliniken AG
Grünauer Straße 5
12557 Berlin
Germany
Phone: +49 (0)30 347 47 44 14
Fax: +49 (0)30 347 47 44 17
E-mail: ir@m1-kliniken.de
Internet: https://www.m1-kliniken.de
ISIN: DE000A0STSQ8
WKN: A0STSQ
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart, Tradegate Exchange
EQS News ID: 1019241

 
End of News DGAP News Service

Editor Details

Last Updated: 09-Apr-2020